(Q33823431)

29 July 2017

title

Severe gamma-hydroxybutyrate withdrawal: a case report and literature review (English)

1 reference

29 July 2017

1 reference

Craig K

1

1 reference

29 July 2017

Gomez HF

series ordinal

2

1 reference

29 July 2017

McManus JL

series ordinal

3

1 reference

29 July 2017

Bania TC

series ordinal

4

1 reference

29 July 2017

publication date

1 January 2000

1 reference

Journal of Emergency Medicine

29 July 2017

published in

1 reference

29 July 2017

volume

18

1 reference

29 July 2017

issue

1

1 reference

29 July 2017

page(s)

65-70

1 reference

Maintaining abstinence from alcohol with gamma-hydroxybutyric acid.

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2899%2900163-8

7 January 2021

Manageability and tolerability of gamma-hydroxybutyric acid in the medium term outpatient treatment of alcoholism.

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2899%2900163-8

7 January 2021

Gamma-hydroxybutyric acid for treatment of alcohol withdrawal syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2899%2900163-8

7 January 2021

Gamma-hydroxybutyric acid for treatment of opiate withdrawal syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2899%2900163-8

7 January 2021

gamma-Hydroxybutyric acid in the treatment of alcohol dependence: a double-blind study.

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2899%2900163-8

7 January 2021

Physical dependence on sodium oxybate.

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2899%2900163-8

7 January 2021

Gamma-hydroxybutyrate: an emerging drug of abuse that causes physical dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2899%2900163-8

7 January 2021

"Grievous bodily harm:" gamma hydroxybutyrate abuse leading to a Wernicke-Korsakoff syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2899%2900163-8

7 January 2021

Gamma-hydroxybutyrate: an overview of the pros and cons for it being a neurotransmitter and/or a useful therapeutic agent

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2899%2900163-8

7 January 2021

Gamma-hydroxybutyrate, a possible neurotransmitter.

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2899%2900163-8

7 January 2021

Gammahydroxybutyric acid

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2899%2900163-8

7 January 2021

Gammahydroxybutyrate and narcolepsy: a double-blind placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2899%2900163-8

7 January 2021

Coma induced by abuse of gamma-hydroxybutyrate (GBH or liquid ecstasy): a case report

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2899%2900163-8

7 January 2021

Coma-inducing drug GHB may be reclassified.

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2899%2900163-8

7 January 2021

Clinical course of gamma-hydroxybutyrate overdose

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2899%2900163-8

7 January 2021

GHB-induced delirium: a case report and review of the literature of gamma hydroxybutyric acid

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2899%2900163-8

7 January 2021

Gammahydroxybutyrate: an endogenous regulator of energy metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2899%2900163-8

7 January 2021

Cross-tolerance to ethanol and gamma-hydroxybutyric acid.

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2899%2900163-8

7 January 2021

gamma-Hydroxybutyric acid in the treatment of alcohol dependence: possible craving development for the drug

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2899%2900163-8

7 January 2021

gamma-Hydroxybutyrate: a health-food product producing coma and seizurelike activity

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2899%2900163-8

7 January 2021

Driving under the influence of GHB?

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2899%2900163-8

7 January 2021

Therapeutic gamma-hydroxybutyric acid monitoring in plasma and urine by gas chromatography-mass spectrometry.

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2899%2900163-8

7 January 2021

10.1016/S0736-4679(99)00163-8

Identifiers

DOI

1 reference

29 July 2017

1 reference